US court convicts Martin Shkreli of defrauding investors

Martin Shkreli, the CEO of Retrophin Pharmaceuticals, has been found guilty of defrauding investors.

    Martin Shkreli, the CEO of Retrophin Pharmaceuticals, has been found guilty of defrauding investors.

    He was best known for raising the price of a life-saving HIV drug.

    Shkreli remains free on bail until he returns to court for sentencing when he could get up to 20 years.

    Al Jazeera's Kristen Saloomey reports from New York City.


    YOU MIGHT ALSO LIKE

    'We will cut your throats': The anatomy of Greece's lynch mobs

    The brutality of Greece's racist lynch mobs

    With anti-migrant violence hitting a fever pitch, victims ask why Greek authorities have carried out so few arrests.

    The rise of Pakistan's 'burger' generation

    The rise of Pakistan's 'burger' generation

    How a homegrown burger joint pioneered a food revolution and decades later gave a young, politicised class its identity.

    From Cameroon to US-Mexico border: 'We saw corpses along the way'

    'We saw corpses along the way'

    Kombo Yannick is one of the many African asylum seekers braving the longer Latin America route to the US.